KG
CBM

Killen Group’s Cambrex Corporation CBM Stock Holding History

Killen Group’s Portfolio CBM Stock Details CBM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-71,104
Closed -$939K – 125
2013
Q3 		$939K Buy
71,104
+3,000
+4% +$42.4K 0.06% 95
2013
Q2 		$951K Buy
+68,104
New +$891K 0.07% 86

Other funds holding CBM

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Killen Group's CBM Position: Q4 2013 in Review

Killen Group sold out of Cambrex Corporation (CBM) in Q4 2013, closing a stake of 71,104 shares — an estimated $939K sold.

Killen Group first reported a position in CBM in Q2 2013 and held it in 2 quarters. The position peaked at $951K in Q2 2013. 144 funds tracked by Wall St. Rank hold CBM as of Q4 2013.

  • Killen Group reported no remaining Cambrex Corporation position as of Q4 2013 after selling out during the quarter.
  • Killen Group sold 71,104 Cambrex Corporation shares in Q4 2013, an estimated $939K.
  • Killen Group first reported a position in Cambrex Corporation in Q2 2013 and held it in 2 quarters.
  • Killen Group's Cambrex Corporation position peaked at $951K in Q2 2013.
  • 144 funds tracked by Wall St. Rank held Cambrex Corporation as of Q4 2013.

Based on Killen Group's 13F filing for Q4 2013, filed 10 Feb 2014.